Re: “Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience.”
✍ Scribed by Miloš D. Pavlović; Dane B. Nenadić
- Book ID
- 113960788
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 83 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The causal relationship between persistent high‐risk human papillomavirus infection and cervical cancer is widely accepted. HR‐HPV DNA testing, alone or in combination with Pap smear testing, may have a role in primary screening. The screening results (VIA, VILI, Pap, and HR‐HPV DNA) of
## Abstract Since infection with oncogenic human papillomavirus (HPV) has been considered a necessary cause of cervical cancer, tests for oncogenic HPV types have been proposed as adjuncts or replacements to Pap cytology. We designed the Canadian Cervical Cancer Screening Trial (CCCaST) to compare